CAPPELLACCI, Loredana
 Distribuzione geografica
Continente #
NA - Nord America 17.959
EU - Europa 9.456
AS - Asia 6.800
SA - Sud America 953
AF - Africa 182
Continente sconosciuto - Info sul continente non disponibili 53
OC - Oceania 24
AN - Antartide 1
Totale 35.428
Nazione #
US - Stati Uniti d'America 17.310
CN - Cina 3.027
RU - Federazione Russa 2.231
IT - Italia 2.030
SG - Singapore 1.803
PL - Polonia 1.326
DE - Germania 943
BR - Brasile 803
UA - Ucraina 605
HK - Hong Kong 594
CA - Canada 562
SE - Svezia 554
GB - Regno Unito 517
FR - Francia 448
FI - Finlandia 317
VN - Vietnam 261
TR - Turchia 258
KR - Corea 252
IN - India 161
IE - Irlanda 146
JP - Giappone 76
CZ - Repubblica Ceca 68
MX - Messico 63
ZA - Sudafrica 57
IR - Iran 56
EU - Europa 52
ES - Italia 45
BD - Bangladesh 44
AR - Argentina 41
BE - Belgio 41
NL - Olanda 41
ID - Indonesia 40
IQ - Iraq 40
NG - Nigeria 32
EC - Ecuador 30
PK - Pakistan 29
AT - Austria 25
CO - Colombia 25
PH - Filippine 18
VE - Venezuela 18
MA - Marocco 17
CL - Cile 16
RO - Romania 16
RS - Serbia 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
CI - Costa d'Avorio 15
GR - Grecia 14
CM - Camerun 12
IL - Israele 12
MY - Malesia 12
SA - Arabia Saudita 12
TW - Taiwan 12
JO - Giordania 11
KE - Kenya 11
DZ - Algeria 10
LT - Lituania 10
TH - Thailandia 10
AL - Albania 9
UZ - Uzbekistan 9
CH - Svizzera 8
EG - Egitto 8
PT - Portogallo 8
AZ - Azerbaigian 6
DK - Danimarca 6
NZ - Nuova Zelanda 6
PE - Perù 6
TN - Tunisia 6
UY - Uruguay 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
KG - Kirghizistan 5
NP - Nepal 5
TT - Trinidad e Tobago 5
ET - Etiopia 4
HU - Ungheria 4
KH - Cambogia 4
KZ - Kazakistan 4
LB - Libano 4
MW - Malawi 4
YE - Yemen 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CR - Costa Rica 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BY - Bielorussia 2
GE - Georgia 2
GU - Guam 2
HN - Honduras 2
JM - Giamaica 2
LU - Lussemburgo 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
Totale 35.400
Città #
Fairfield 1.547
Jacksonville 1.505
Ashburn 1.421
Woodbridge 1.384
Houston 970
Warsaw 951
Chandler 937
Ann Arbor 763
Singapore 755
Wilmington 700
Dallas 688
Seattle 674
Boardman 621
Hong Kong 574
Camerino 533
Cambridge 482
Beijing 474
Nanjing 470
Toronto 388
Kraków 361
Los Angeles 286
The Dalles 273
New York 262
San Mateo 251
Seoul 223
Tongling 218
Lawrence 204
Princeton 204
Istanbul 199
Columbus 190
Düsseldorf 179
Dearborn 177
Nanchang 171
Ogden 160
Helsinki 143
Dublin 139
Moscow 115
Buffalo 112
Lachine 112
London 111
Chicago 110
Shanghai 110
Milan 101
Tianjin 90
Shenyang 89
Ho Chi Minh City 84
Guangzhou 83
São Paulo 82
Hebei 81
Kunming 81
Centro 77
Jiaxing 70
San Diego 66
Ancona 63
Tokyo 60
Jinan 59
Falls Church 55
Washington 54
Stockholm 53
Bremen 52
Hangzhou 51
Hanoi 48
Leawood 48
Brooklyn 46
Changsha 46
Rome 46
Council Bluffs 45
Redwood City 44
Venezia 43
Brno 42
Denver 42
Dong Ket 42
Santa Clara 41
Munich 40
Brussels 39
Orem 39
Johannesburg 37
Zhengzhou 37
Wuhan 36
Hefei 34
Macerata 34
Frankfurt am Main 32
Philadelphia 32
Chennai 31
Phoenix 31
Montreal 29
Redondo Beach 29
Atlanta 28
Mexico City 27
Verona 27
Auburn Hills 26
Mumbai 26
Rio de Janeiro 26
Ankara 25
Acquaviva 24
Nuremberg 24
Ardabil 23
Macapá 23
San Francisco 23
Perugia 22
Totale 22.835
Nome #
Trypanosoma brucei inhibition by essential oils from medicinal and aromatic plants traditionally used in Cameroon (Azadirachta indica, Aframomum melegueta, Aframomum daniellii, Clausena anisata, Dichrostachys cinerea and Echinops giganteus) 437
Diverse biological effects of the ajwain oil from Iranian Trachyspermum ammi 428
CHEMICAL COMPOSITION, ANTIMICROBIAL AND ANTIPROLIFERATIVE ACTIVITIES OF THE ESSENTIAL OIL FROM CAMEROONIAN ERIGERON FLORIBUNDUS 394
Biological activities of the essential oil from Erigeron floribundus 377
Mexican sunflower (Tithonia diversifolia, Asteraceae) volatile oil as a selective inhibitor of Staphylococcus aureus nicotinate mononucleotide adenylyltransferase (NadD) 341
An overlooked horticultural crop, Smyrnium olusatrum, as a potential source of compounds effective against African trypanosomiasis 312
CHEMICAL COMPOSITION OF TEN ESSENTIAL OILS FROM CALOPHYLLUM INOPHYLLUM LINN AND THEIR TOXICITY AGAINST ARTEMIA SALINA 305
The crop-residue of fiber hemp cv Futura 75: from a waste product to a source of botanical insecticides 292
Essential oil and furanosesquiterpenes from myrrh oleo-gum resin: a breakthrough in mosquito vector management 287
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 286
Mosquito control with green nanopesticides: towards the One Health approach? A review of non-target effects 270
SINTESI E VALUTAZIONE BIOLOGICA DI INIBITORI DI ENZIMI CHIAVE NEL METABOLISMO DI BIOFILM BATTERICI 268
4-acyl-5-pyrazolone-based hydrazones as novel anti-Trypanosoma brucei agents: structural design, synthesis and biological evaluation 265
Antitrypanosomal activity of Tithonia Diversifolia 257
The essential oil from industrial hemp (Cannabis sativa L.) by-products as an effective tool for insect pest management in organic crops 256
8-Aza analogues of deaza purine nucleosides. Synthesis and biological evaluation of 8-aza-1-deazaadenosine and 2'-deoxy-8-aza-1-deazaadenosine 250
Identification of Onosma visianii Roots Extract and Purified Shikonin Derivatives as Potential Acaricidal Agents against Tetranychus urticae 248
Isofuranodiene and germacrone from Smyrnium olusatrum essential oil as acaricides and oviposition inhibitors against Tetranychus urticae: impact of chemical stabilization of isofuranodiene by interaction with silver triflate 241
Oviposition inhibitory activity of the Mexican sunflower Tithonia diversifolia (Asteraceae) polar extracts against the two-spotted spider mite Tetranychus urticae (Tetranychidae) 238
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. 236
Synergized mixtures of Apiaceae essential oils and related plant-borne compounds: larvicidal effectiveness on the filariasis vector Culex quinquefasciatus Say 234
Development of C-Methyl Branched Purine Ribonucleoside Analogs: Chemistry, Biological Activity and Therapeutic Potential 231
8-Azaxanthine derivatives as antagonists of adenosine receptors. 225
Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors 222
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 221
8-Aza-1-deaza purine nucleosides as antiviral agents. 220
Targeting Nucleotide Dimers Containing Antiviral Nucleosides 219
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 218
2’-C-Methyl derivatives of tecadenoson and 2-chloro-tecadenoson with increased selectivity for human A1 adenosine receptor 215
Synthesis and antiviral activity of 8-aza analogs of chiral [2-(Phosphono-methoxy)propyl]guanines. 214
ATP-mimetics derived from 2 '(3 ')-C-methyladenosine as human P2Y2 agonists 213
A new facile synthesis and antiviral activity of oxazofurin 213
4’-TETRAZOLYL-ALKYL-N6-SUBSTITUTED ADENOSINE DERIVATIVES AS HIGHLY POTENT DUAL ACTING A1 ADENOSINE RECEPTOR AGONISTS AND A3 ADENOSINE RECEPTOR ANTAGONISTS 213
Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene Complexes 207
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 206
5’-deoxy-5’-N-pyrazolyl-N6-substituded adenosine derivates as A1 adenosine receptor agonists: synthesis and antinociception in mice 206
Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade 204
5’-Carbamoyl Derivatives of 2'-C-Methyl-purine Nucleosides as Selective A1 Adenosine Receptor Agonists: Affinity, Efficacy and Selectivity for A1 Receptor from Different Species. 203
Acyclic nucleotides related to clitocine: synthesis and anti-HIV activity 203
Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents 200
Synthesis and Biological Evaluation of NAD Analogs as Human Pyridine Nucleotide Adenylyltransferase Inhibitors 200
New Half-Sandwich Ruthenium(II) Complexes bearing Hydrazone Ligands: Organometallic Chemistry and Bioactivity 200
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 199
5'-CHLORO-5'-DEOXY-N6-(±)-endo-NORBORNYLADENOSINE, A POTENT AND HIGHLY SELECTIVE HUMAN A1 ADENOSINE RECEPTOR AGONIST, PREVENTS HYPERALGESIA/ALLODYNIA AND EARLY OVER-EXPRESSION OF PRO-APOPTOTIC AND PRO-INFLAMMATORY GENES IN A MICE MODEL OF NEUROPATHIC PAIN 199
Efficacy of Origanum syriacum Essential Oil against the Mosquito Vector Culex quinquefasciatus and the Gastrointestinal Parasite Anisakis simplex, with Insights on Acetylcholinesterase Inhibition 199
Rationale for developing novel mosquito larvicides based on isofuranodiene microemulsions 198
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 196
BIOASSAY-GUIDED FRACTIONATION OF TITHONIA DIVERSIFOLIA SECONDARY METABOLITES AGAINST TRYPANOSOMA BRUCEI 195
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF RIBOSE-MODIFIED ADENOSINE DERIVATIVES AS P1 RECEPTOR LIGANDS 192
A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus 191
5′-C-Ethyl-tetrazolyl-N6-Substituted Adenosine and 2-Chloro-adenosine Derivatives as Highly Potent Dual Acting A1 Adenosine Receptor Agonists and A3 Adenosine Receptor Antagonists 191
ADP- and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 receptor ligands 191
Purine and pyrimidine nucleoside analogs of 3'-C-methyladenosine as antitumor agents 191
Insights into the GTP‐dependent allosteric control of c‐di‐GMP hydrolysis from the crystal structure of PA0575 protein from Pseudomonas aeruginosa 191
Identification of highly effective antitrypanosomal compounds in essential oils from the Apiaceae family 190
8-Aza derivatives of 3-deazapurine nucleosides. Synthesis and in vitro evaluation of antiviral and antitumor activity 189
A new tiazofurin pronucleotide: synthesis and biological evaluation of CycloSaligenyl-tiazofurin monophosphate 188
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 187
Acute and sub-lethal toxicity of eight essential oils of commercial interest against the filariasis mosquito Culex quinquefasciatus and the housefly Musca domestica 187
Stereoselective synthesis of nicotinamide β-riboside and nucleoside analogs 186
Preparation of purine and 8-azapurine derivatives for treatment of acquired immune deficiency syndrome. 184
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 184
Novel dual acting 5’-C-ethyl-tetrazolyl-N6-substituted adenosine derivatives: synthesis and biological evaluation 184
Exploring the Insecticidal Potential of Boldo (Peumus boldus) Essential Oil: Toxicity to Pests and Vectors and Non-target Impact on the Microcrustacean Daphnia magna 184
Synthesis and antitumor activity of a heterodinucleotide of BVDU and Gemcitabine 182
null 182
Pharmacokinetic and antiretroviral activity in mice of oral [P1,P2-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 182
The A1 Adenosine Receptor as a New Player in Microglia Physiology 180
Isosteric Analogues of Nicotinamide Adenine Dinucleotide Derived from Furanfurin, Thiophenfurin, and Selenophenfurin as Mammalian Inosine Monophosphate dehydrogenase (Type I and II) Inhibitors 180
8-Aza-analogues of PMEA and PMEG: synthesis and in vitro anti-HIV activity. 179
Dinucleoside polyphosphate NAD analogs as potential NMN adenylyltransferase inhibitors. Synthesis and biological evaluation 179
Synthesis, Biological Evaluation and Molecular Modeling of Ribose-modified Adenosine Analogues as Adenosine Receptor Agonists 179
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 179
Identification of Tagitinin C from Tithonia diversifolia as antitrypanosomal compound using bioactivity-guided fractionation 179
Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2',3'-didehydro-2',3'-dideoxy-3-deazaadenosine, 2',3'-dideoxy-3-deazaadenosine and some 2',3'-dideoxy-3-deazaadenosine 5'-dialkyl phosphates 178
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells 178
Synthesis and antiviral evaluation of 1-deaza-8-aza- and 3-deaza-8-aza-purine nucleosides 178
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 178
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3’-C-methyladenosine in leukaemia cells 177
Synthesis, antitumor activity and crystallographic studies of analogues of tiazofurin 176
Carlina oxide from Carlina acaulis root essential oil acts as a potent mosquito larvicide 176
2'-C-Methyl-2-chloro-N6-cyclopentyladenosine, a potent and highly selective A1 adenosine receptor agonist, has antinociceptive activity and modulates RVM on-and-off cell activities 175
Synthesis and IMP dehydrogenase (type I and type II) inhibitory activity of isosteric NAD analogs derived from thiophenfurin and furanfurin 175
2'-C-Methyl analogs of selective adenosine receptors agonists: synthesis and binding studies 175
5’-CHLORO-5’-DEOXY-N6-SUBSTITUTED ADENOSINE DERIVATIVES: SYNTHESIS, ADENOSINE RECEPTOR AFFINITY AND ANTINOCICEPTIVE ACTIVITY 175
Synthesis and Biological Evaluations of Novel Arene Ru(II) Complexes of 4-acyl-5-pyrazolone-based Hydrazone Ligands 175
Ligand Design for N,O- or N,N‐Pyrazolone-Based Hydrazones Ruthenium(II)-Arene Complexes and Investigation of Their Anticancer Activity 175
NMN/NaMN adenylyltransferase (NMNAT) and NAD kinase (NADK) inhibitors: chemistry and potential therapeutic applications 174
5'-Chloro-5'-deoxy-N6-(±)-endo-norbornyladenosine, a potent and highly selective human A1 adenosine receptor agonist modulates neuropathic pain in mice. 172
Not just popular spices! Essential oils from Cuminum cyminum and Pimpinella anisum are toxic to insect pests and vectors without affecting non-target invertebrates 172
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y(2) and P2Y(6) receptor agonists 172
Structure-activity relationships of tiazofurin analogs: synthesis and computational studies of 4'-thio derivatives of thiophenfurin and furanfurin 171
Synthesis, structure, and antiproliferative activity of selenophenfurin, an IMP dehydrogenase inhibitor analogue of selenazofurin. 171
Ribose-modified mizoribine analogues: synthesis and biological evaluation 171
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 171
Synthesis and anti-HIV activity of isonucleosides and acyclic nucleotides related to clitocine 171
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues 170
Encapsulation of Carlina acaulis essential oil and carlina oxide to develop long‑lasting mosquito larvicides: microemulsions versus nanoemulsions 170
Synthesis and cytotoxic activity of selenophenfurin, a new inhibitor of IMP dehydrogenase 169
Adenosine receptors as promising targets for the management of ocular diseases 169
Totale 21.186
Categoria #
all - tutte 146.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.551 0 0 0 0 0 274 506 107 358 157 778 371
2021/20222.295 166 609 62 104 136 116 81 160 192 209 210 250
2022/20232.883 340 60 143 332 320 360 11 203 524 231 269 90
2023/20242.515 296 151 166 81 132 318 130 110 254 133 58 686
2024/20257.310 322 165 661 307 265 360 899 1.791 638 512 369 1.021
2025/20265.337 593 901 892 1.353 976 622 0 0 0 0 0 0
Totale 36.188